Company / Interest Expense
Niagen Bioscience, Inc. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$3.0K
FY2023
5-year range
-$55.0K / $71.0K
FY2019-FY2023
Trend
+105.5%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense returned to growth in FY2023 after 2 years of decline, reaching $3,000.
Based on SEC 10-K filings.
$3,000 in FY2023 with a 5-year CAGR of -54.5%.
Improved from $71,000 to $3,000 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -84.8%
- 5-Year CAGR
- -54.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -54.5%, indicating a declining trend.
- In FY2023, interest expense increased 105.5% year-over-year.
- Peak interest expense was recorded in FY2020.
- Lowest interest expense in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $3.0K | +105.5% |
| FY2022 | -$55.0K | -177.5% |
| FY2021 | $71.0K | -91.6% |
| FY2020 | $847.0K | +0.0% |
| FY2019 | $847.0K | +453.6% |
| FY2018 | $153.0K | +0.0% |
| FY2017 | $153.0K | -54.1% |
| FY2016 | $333.3K | -41.2% |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026